66 results on '"Lewis, Jason S"'
Search Results
2. Production and regulatory issues for theranostics
3. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
4. Novel Tracers and Radionuclides in PET Imaging
5. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
6. Medical imaging and nuclear medicine: a Lancet Oncology Commission
7. Applications of nuclear-based imaging in gene and cell therapy: Probe considerations
8. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
9. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue
10. Radiotheranostics: a roadmap for future development
11. Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer
12. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model
13. Paradigms for Precision Medicine in Epichaperome Cancer Therapy
14. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
15. A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
16. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model
17. Applications of pHLIP Technology for Cancer Imaging and Therapy
18. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
19. Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
20. Imaging of human epidermal growth factor receptors for patient selection and response monitoring – From PET imaging and beyond
21. Applications of pHLIP Technology for Cancer Imaging and Therapy
22. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer
23. Synthesis and evaluation of an 18 F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas
24. A comparative evaluation of the chelators H 4 octapa and CHX-A″-DTPA with the therapeutic radiometal 90 Y
25. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
26. Fully-automated synthesis of 16β- 18 F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer
27. Evaluation of Hypoxia With Copper-Labeled Diacetyl-bis(N-Methylthiosemicarbazone)
28. Synthesis and evaluation of 18F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression
29. H4octapa vs H4C3octapa: The difference of a single carbon atom
30. 3,4,3-(LI-1,2-HOPO): An alternative chelator for 89Zr radiopharmaceuticals
31. The site-specific radiometallation of antibodies on the heavy chain glycans
32. Influence of free fatty acids on glucose uptake in prostate cancer cells
33. Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: Studies on the endogenous opioid peptide α-neoendorphin
34. Antilipolytic drug boosts glucose metabolism in prostate cancer
35. PET imaging with 89Zr: From radiochemistry to the clinic
36. An improved strategy for the synthesis of [18F]-labeled arabinofuranosyl nucleosides
37. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer
38. The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
39. 89Zr-chemistry in the design of novel radiotracers for immunoPET
40. Improved synthesis of 2′-deoxy-2′-[18F]-fluoro-1-β-d-arabinofuranosyl-5-iodouracil ([18F]-FIAU)
41. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) – Potential combination agents for the PET imaging of hypoxia
42. Standardized methods for the production of high specific-activity zirconium-89
43. Melanoma imaging using 111In-, 86Y- and 68Ga-labeled CHX-A″-Re(Arg11)CCMSH
44. 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
45. Copper-64 Radiopharmaceuticals for Oncologic Imaging
46. Evaluation of a bromine-76-labeled progestin 16α,17α-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies
47. Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer
48. Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
49. Gallium-68-labeled DOTA-rhenium-cyclized α-melanocyte-stimulating hormone analog for imaging of malignant melanoma
50. In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.